Aberrant expression of STYK1 and E-cadherin confer a poor prognosis for pancreatic cancer patients

Previous studies showed that aberrant Serine/threonine/tyrosine kinase 1 (STYK1, also known as NOK) or/and E-cadherin were involved in the progression of some types of human cancers. However, whether they contributed to the development of pancreatic cancer was unknown. Here, we investigated the prog...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Luguang, Ma, Chao, Bian, Yun, Shao, Chengwei, Wang, Tiegong, Li, Jing, Chong, Xiaodan, Su, Li, Lu, Jianping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762325/
https://www.ncbi.nlm.nih.gov/pubmed/29340057
http://dx.doi.org/10.18632/oncotarget.22794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762325/
https://www.ncbi.nlm.nih.gov/pubmed/29340057
http://dx.doi.org/10.18632/oncotarget.22794

Ejemplares similares